Gernandt & Danielsson advises in Orexo’s bond issue

Gernandt & Danielsson advises in Orexo’s issue of corporate bonds amounting to SEK 500 million within a framework amount of SEK 1,000 million.

Orexo AB (publ), a specialty pharmaceutical company based in Sweden, has issued unsecured floating rate corporate bonds amounting to SEK 500 million with the possibility to issue additional bonds amounting to SEK 500 million. The issue was conducted through a private placement directed at selected Swedish and international institutional investors and the company has undertaken to list the bond on NASDAQ OMX Stockholm.

Gernandt & Danielsson has advised the company and its financial adviser Pareto Securities with a team consisting of the partner Mikael Borg, senior associate Fredrik Eklund and associate Marcus Karner.